Rohto Pharmaceutical Co Ltd represents a set of values and corporate philosophy that focuses on improving people's lives through innovative healthcare products. The company is committed to providing safe, effective, and high-quality solutions to meet various medical and beauty needs. Rohto Pharmaceutical Co Ltd believes in continuous research and development, ensuring that their products are backed by scientific expertise. With a strong emphasis on customer satisfaction, the company aims to contribute to society by promoting better health and well-being. Rohto Pharmaceutical Co Ltd's dedication to excellence and its mission to enhance the lives of individuals make it a trusted name in the pharmaceutical industry.

Rohto Pharmaceutical Co Ltd is primarily present in Japan, its home country. As a leading pharmaceutical company, Rohto has established its presence and reputation domestically. With a strong focus on developing and marketing innovative healthcare products, Rohto has gained a significant market share in Japan. The company's commitment to providing high-quality healthcare solutions has made it a trusted brand among consumers in the region. Rohto continues to expand its operations and aims to bring its products to other countries and regions in the future.

Rohto Pharmaceutical Co Ltd, a renowned company in the pharmaceutical industry, has achieved several significant milestones. The company has successfully expanded its global presence through strategic partnerships and acquisitions, strengthening its position in the market. Rohto Pharmaceutical Co Ltd has also developed innovative and high-quality healthcare products, addressing various medical needs. With a focus on research and development, the company has made breakthroughs in the pharmaceutical sector, contributing to advancements in healthcare. Moreover, Rohto Pharmaceutical Co Ltd has gained recognition for its commitment to ensuring the well-being and satisfaction of its customers worldwide.

Rohto Pharmaceutical Co Ltd, founded in 1899, is a well-established Japanese healthcare company. With a rich history spanning over a century, the company has garnered a reputation for manufacturing and distributing innovative pharmaceutical products globally. Rohto Pharmaceutical specializes in developing healthcare solutions across various domains, including skincare, eye care, oral care, and pain relief. With a strong commitment to research and development, the company consistently delivers high-quality, reliable products that cater to diverse consumer needs. Over the years, Rohto Pharmaceutical has become synonymous with excellence in the healthcare industry, consistently striving to improve the overall well-being and health of individuals worldwide.

The main competitors of Rohto Pharmaceutical Co Ltd in the market include Johnson & Johnson, Pfizer Inc., Novartis International AG, and GlaxoSmithKline plc.

Rohto Pharmaceutical Co Ltd is primarily active in the healthcare and personal care industries.

The business model of Rohto Pharmaceutical Co Ltd revolves around developing, manufacturing, and marketing a wide range of innovative healthcare products. Rohto Pharmaceutical aims to contribute to the well-being of individuals by providing high-quality medicines, cosmetics, and functional foods. As a leading Japanese company in the pharmaceutical industry, Rohto Pharmaceutical focuses on research and development to create breakthrough solutions for various health concerns. With a strong commitment to improving people's lives, Rohto Pharmaceutical continues to expand its product portfolio while ensuring adherence to strict quality standards.

Rohto Pharmaceutical Co hissesinin F/K oranı 25,67.

Rohto Pharmaceutical Co KUV 2,93 dir.

Rohto Pharmaceutical Co için AlleAktien Kalite Skoru 9/10'dur.

Rohto Pharmaceutical Co cirosu 270,84 Milyar JPY dir.

Rohto Pharmaceutical Co karı 30,94 Milyar JPY olarak gerçekleşmiştir.

Rohto Pharmaceutical Co Ltd is a Japanese company specializing in the manufacturing and sale of healthcare products. It was founded in 1899 and has its headquarters in Osaka, Japan. It is part of the Rohto-Mentholatum group and operates worldwide. The company's main divisions are ophthalmic, dermatological, and oral care products. In the ophthalmic division, Rohto Pharmaceutical holds a leading position in the Japanese market, offering eye drops, lens care products, and eye washes for both medical and cosmetic purposes. In dermatology, the company provides various skin creams, pain ointments, and lip balms to help with skin issues such as acne, eczema, psoriasis, and other irritations. Their oral care products include toothpaste, mouthwash, and gum. Rohto Pharmaceutical also offers a range of pain relievers for headaches, backaches, muscle pains, and menstrual discomfort, marketed under brand names such as "Zanidip" and "Sai-Ro." With a strong presence in the Asian market, Rohto Pharmaceutical continues to expand into North America and Europe. It has subsidiaries in China, Hong Kong, Taiwan, and Thailand, as well as branches in North America and Europe. The company has partnerships with local businesses in various countries and operates joint ventures to expand its global presence. Rohto Pharmaceutical's business model relies on innovation and quality control. It invests in research and development to develop new products and improve existing ones. The company also implements rigorous controls in all its production facilities to ensure its products meet the highest quality standards. Rohto Pharmaceutical holds multiple patents for its products and technologies. The company is known for its marketing strategies, prioritizing brand awareness and utilizing various media to promote its products. It also maintains a presence on social media and employs online marketing to sell its products. Rohto Pharmaceutical is expected to continue expanding and entering new markets. With a strong position in the Asian market, it is likely to focus on expanding in North America and Europe. Continued investment in research and development and the introduction of new products are also expected to drive the company's growth. Overall, the future of Rohto Pharmaceutical is promising, and it is expected to remain a significant player in the healthcare industry.

Rohto Pharmaceutical Co, yılda 2 kez dağıtılmak üzere 41,00 JPY tutarında temettü ödemektedir.

Rohto Pharmaceutical Co, yılda 2 kez temettü ödemesi yapar.

Rohto Pharmaceutical Co şirketinin ISIN kodu JP3982400008’dir.

Rohto Pharmaceutical Co 'nin WKN'si 858075 'dir.

Rohto Pharmaceutical Co için Ticker 4527.T’dir.

Son 12 ay içerisinde Rohto Pharmaceutical Co, 30,00 JPY tutarında bir temettü ödedi. Bu, yaklaşık olarak 0,86 % oranında bir temettü verimine denk gelmektedir. Gelecek 12 ay için Rohto Pharmaceutical Co, tahmini olarak 32,04 JPY tutarında bir temettü ödemesi yapacak.

Rohto Pharmaceutical Co şirketinin mevcut temettü verimi 0,86 %.

Rohto Pharmaceutical Co dönemsel olarak temettü ödemesi yapar. Bu ödemeler Ekim, Nisan, Ekim, Nisan aylarında gerçekleştirilir.

Rohto Pharmaceutical Co, son 23 yıl içerisinde her yıl temettü ödedi.

Önümüzdeki 12 ay için 32,04 JPY tutarında temettü ödenmesi beklenmektedir. Bu, 0,92 % oranında bir temettü verimidir.

Rohto Pharmaceutical Co, 'Sabit Tüketim Malları' sektörüne atanmıştır.

Son Rohto Pharmaceutical Co tarihinde 15 JPY tutarındaki en son temettüyü alabilmek için, hisseyi 27.09.2024 tarihindeki Ex-Tag'den önce portföyünde bulundurman gerekiyordu.

Son ödeme tarihi 01.12.2024 olarak gerçekleşti.

2023 yılında Rohto Pharmaceutical Co tarafından 24 JPY olarak temettüler dağıtıldı.

Rohto Pharmaceutical Co hisselerinin temettüleri JPY olarak dağıtılır.